Home LiteratureArticle Details
PMID: 10417282 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

American journal of human genetics ·Vol. 65 ·No. 2 ·1999-08-00 ·Pages 397-412

Aouizerat BE, Allayee H, Cantor RM, Davis RC, Lanning CD, Wen PZ, Dallinga-Thie GM, de Bruin TW, Rotter JI, Lusis AJ

Abstract

Familial combined hyperlipidemia (FCHL) is a common familial lipid disorder characterized by a variable pattern of elevated levels of plasma cholesterol and/or triglycerides. It is present in 10%-20% of patients with premature coronary heart disease. The genetic etiology of the disease, including the number of genes involved and the magnitude of their effects, is unknown. Using a subset of 35 Dutch families ascertained for FCHL, we screened the genome, with a panel of 399 genetic markers, for chromosomal regions linked to genes contributing to FCHL. The results were analyzed by use of parametric-linkage methods in a two-stage study design. Four loci, on chromosomes 2p, 11p, 16q, and 19q, exhibited suggestive evidence for linkage with FCHL (LOD scores of 1.3-2.6). Markers within each of these regions were then examined in the original sample and in additional Dutch families with FCHL. The locus on chromosome 2 failed to show evidence for linkage, and the loci on chromosome 16q and 19q yielded only equivocal or suggestive evidence for linkage. However, one locus, near marker D11S1324 on the short arm of human chromosome 11, continued to show evidence for linkage with FCHL, in the second stage of this design. This region does not contain any strong candidate genes. These results provide evidence for a candidate chromosomal region for FCHL and support the concept that FCHL is complex and heterogeneous.

MeSH Terms
Adult Chromosomes, Human, Pair 11/genetics Female Genetic Linkage Genetic Markers Genome, Human Genotype Humans Hyperlipidemia, Familial Combined/genetics Male Matched-Pair Analysis Middle Aged Molecular Sequence Data Multifactorial Inheritance Netherlands Nuclear Family Pedigree Research Design Statistics, Nonparametric
Chemicals
Genetic Markers
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Aouizerat B E
Departments of 1Microbiology and Molecular Genetics, Medicine, Human Genetics, Molecular Biology Institute, University of California, UCLA School of Medicine Los Angeles, CA 90095-1679, USA.
Allayee H
Cantor R M
Davis R C
Lanning C D
Wen P Z
Dallinga-Thie G M
de Bruin T W
Rotter J I
Lusis A J
References (51)
51 references, click to expand
  1. Complete multipoint sib-pair analysis of qualitative and quantitative traits.
    Am J Hum Genet. 1995 Aug;57(2):439-54 PMID: 7668271
  2. The acylation stimulating protein-adipsin system.
    Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S34-8 PMID: 7550536
  3. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.
    Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):748-54 PMID: 9108790
  4. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Arterioscler Thromb Vasc Biol. 1997 May;17(5):834-40 PMID: 9157945
  5. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Arterioscler Thromb Vasc Biol. 1997 May;17(5):841-50 PMID: 9157946
  6. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity.
    Eur J Clin Invest. 1997 Oct;27(10):802-11 PMID: 9373757
  7. Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group.
    Eur J Clin Invest. 1998 Jan;28(1):24-32 PMID: 9502184
  8. Parametric and nonparametric linkage analysis: a unified multipoint approach.
    Am J Hum Genet. 1996 Jun;58(6):1347-63 PMID: 8651312
  9. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
    Am J Hum Genet. 1996 Apr;58(4):812-22 PMID: 8644746
  10. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.
    Nat Genet. 1996 Jun;13(2):161-6 PMID: 8640221
  11. In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia.
    Atherosclerosis. 1996 Mar;121(1):75-84 PMID: 8678926
  12. Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations.
    Genet Epidemiol. 1996;13(2):117-37 PMID: 8722742
  13. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III.
    J Lipid Res. 1996 Jan;37(1):136-47 PMID: 8820109
  14. Improved set of short-tandem-repeat polymorphisms for screening the human genome.
    Am J Hum Genet. 1997 Feb;60(2):459-60 PMID: 9012420
  15. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy.
    Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):72-82 PMID: 9012640
  16. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease.
    J Lipid Res. 1996 Dec;37(12):2627-37 PMID: 9017514
  17. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
    J Clin Invest. 1997 Mar 1;99(5):953-61 PMID: 9062353
  18. Inheritance of combined hyperlipoproteinemia: evidence for a new lipoprotein phenotype.
    Am J Med. 1973 Feb;54(2):148-60 PMID: 4346680
  19. Family study of serum lipids and lipoproteins in coronary heart-disease.
    Lancet. 1973 May 5;1(7810):954-9 PMID: 4121585
  20. The investigation of linkage between a quantitative trait and a marker locus.
    Behav Genet. 1972 Mar;2(1):3-19 PMID: 4157472
  21. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.
    J Clin Invest. 1973 Jul;52(7):1544-68 PMID: 4718953
  22. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Metabolism. 1981 Sep;30(9):856-68 PMID: 7266376
  23. Complex segregation analysis of hypertriglyceridemia.
    Hum Hered. 1981;31(4):222-6 PMID: 7287013
  24. Complex segregation analysis of hyperlipidemia in a Seattle sample.
    Hum Hered. 1982;32(1):24-36 PMID: 7068156
  25. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    J Lipid Res. 1983 Feb;24(2):147-55 PMID: 6403642
  26. Strategies for multilocus linkage analysis in humans.
    Proc Natl Acad Sci U S A. 1984 Jun;81(11):3443-6 PMID: 6587361
  27. Construction of human linkage maps: likelihood calculations for multilocus linkage analysis.
    Genet Epidemiol. 1986;3(1):39-52 PMID: 3957003
  28. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
    Am J Hum Genet. 1989 Mar;44(3):388-96 PMID: 2916582
  29. cDNA cloning and expression of oxysterol-binding protein, an oligomer with a potential leucine zipper.
    J Biol Chem. 1989 Oct 5;264(28):16798-803 PMID: 2777807
  30. cDNA cloning of human oxysterol-binding protein and localization of the gene to human chromosome 11 and mouse chromosome 19.
    Genomics. 1990 May;7(1):65-74 PMID: 1970801
  31. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.
    Nature. 1991 Jan 10;349(6305):161-4 PMID: 1670899
  32. Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver.
    J Inherit Metab Dis. 1991;14(6):915-22 PMID: 1779650
  33. Familial combined hyperlipidaemia: 1973-1991.
    Neth J Med. 1992 Feb;40(1-2):83-95 PMID: 1579191
  34. Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
    Arterioscler Thromb. 1993 Jun;13(6):804-14 PMID: 8499400
  35. Faster sequential genetic linkage computations.
    Am J Hum Genet. 1993 Jul;53(1):252-63 PMID: 8317490
  36. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
    Arterioscler Thromb. 1993 Jul;13(7):1110-8 PMID: 8318511
  37. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Genet Epidemiol. 1993;10(4):257-70 PMID: 8224806
  38. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.
    Arterioscler Thromb. 1994 Aug;14(8):1233-49 PMID: 8049184
  39. Avoiding recomputation in linkage analysis.
    Hum Hered. 1994 Jul-Aug;44(4):225-37 PMID: 8056435
  40. Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.
    Arterioscler Thromb. 1994 Nov;14(11):1687-94 PMID: 7947591
  41. Identifying complex disease genes: progress and paradigms.
    Nat Genet. 1994 Oct;8(2):108-10 PMID: 7772120
  42. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    J Clin Invest. 1995 May;95(5):2161-9 PMID: 7738184
  43. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.
    Nat Genet. 1998 Apr;18(4):369-73 PMID: 9537421
  44. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.
    Nat Genet. 1998 Apr;18(4):374-7 PMID: 9537422
  45. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.
    Am J Hum Genet. 1998 Aug;63(2):577-85 PMID: 9683614
  46. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.
    Am J Hum Genet. 1998 Aug;63(2):586-94 PMID: 9683593
  47. Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol.
    Biochem J. 1998 Nov 15;336 ( Pt 1):247-56 PMID: 9806908
  48. Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization.
    J Biol Chem. 1998 Nov 20;273(47):31621-8 PMID: 9813079
  49. Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol.
    J Lipid Res. 1999 Jan;40(1):109-16 PMID: 9869656
  50. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.
    J Hum Genet. 1999;44(1):10-4 PMID: 9929969
  51. Novel genes for familial combined hyperlipidemia.
    Curr Opin Lipidol. 1999 Apr;10(2):113-22 PMID: 10327279
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
1999-08-00
Pages
397-412
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1377938
Subset
IM
Grants
NHLBI NIH HHS · HL-28481 · United States
NCRR NIH HHS · P41 RR03655 · United States
Databases
OMIM
144250
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com